20th Drug Discovery Strategic Summit 2025

Amsterdam, NL
November 19-20, 2025

The Drug Discovery Strategic Summit is a premier, invitation-only event that brings together over 120 leaders from the pharmaceutical and biotech industries. The summit is designed to ignite innovation, foster collaboration, and provide critical insights into the future of drug discovery. Attendees will experience visionary keynotes, one-on-one sessions with decision-makers, and a showcase of pioneering technologies that are shaping the next era of medicine.

Ewa’s keynote will focus on how digital chemistry and retrosynthesis are transforming the landscape of drug discovery. As a recognized leader in cheminformatics and synthetic route design, Ewa will share her perspective on:

  • The evolving role of computer-aided synthesis planning in reducing risk, supporting sustainability, and enabling ingenuity in drug discovery.
  • How SYNTHIA® Retrosynthesis Software empowers chemists to rapidly design novel, efficient, and greener synthetic routes, accelerating the path from idea to candidate molecule.
  • Case studies demonstrating how digital tools like Synthia® have enabled faster, more cost-effective, and environmentally conscious drug development.
  • The future of collaboration between human expertise and AI, and how this synergy is unlocking new possibilities for pharmaceutical innovation.

     

The DDSS is renowned for its expertly curated keynote presentations and its focus on actionable strategies for the industry’s most pressing challenges. Ewa’s participation underscores the growing importance of digital transformation in drug discovery, and highlights Synthia’s commitment to empowering scientists with the tools they need to innovate faster and smarter.

 

Join us in Amsterdam

Speaker

Dr. Ewa Gajewska holds a position of a Head of Product Management in Merck, Darmstadt, Germany where she leads the development of SYNTHIA® Retrosynthesis Software. She graduated in biotechnology and chemistry from the Gdansk University of Technology and was a recipient of the Outstanding Achievements Award from Poland’s Minister of Science and Higher Education. In 2020 she received her PhD from the Institute of Organic Chemistry at the Polish Academy of Sciences. Her doctoral work was devoted to development of the SYNTHIA® Retrosynthesis Software for computer-assisted synthetic planning.  Her passion for tackling complex scientific challenges within commercial settings and the unique blend of her interdisciplinary skills drive the realization of innovative features of SYNTHIA® Retrosynthesis Software.